Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

veeva_webinar

Free Webinar: How will quality management change by 2025?

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva

Following on from the success of our previous free webinar sessions, Pharmafocus is partnering
News

Pricing Consultant Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)
Appointment

Head of Product Innovation Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)
Appointment

Development Manager Job Profile and Description

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …
Appointment

ABPI reveals 10% increase in HCP payment disclosure

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, disclosure, disclosure uk

The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for …
News

Eli Lilly arthritis drug outperforms Humira and receives NICE backing

June 30, 2017 Medical Communications, Research and Development, Sales and Marketing Eli Lilly, NICE, Olumiant, rheumatoid arthritis

Eli Lilly’s rheumatoid arthritis (RA) drug Olumiant (baricitinib) has been deemed cost-effective by NICE and has been recommended to be …
News
shutterstock_212432119

The pharmaceutical research and development challenge

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Mylan …
News
shutterstock_273326141

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

June 29, 2017 Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …
News
ingram_headshot

Sarepta appoints ex-Allergan President as new CEO

June 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sarepta Therapeutics

Sarepta Therapeutics has announced the appointment of ex-Allergan President Doug Ingram as the company’s new CEO – it’s third in …
Appointment
pounds_stacked

Regulators get aggressive on matters excessive

June 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …
Feature
novartis_headquarters

Novartis gains first-line approval for Zykadia in lung cancer

June 29, 2017 Research and Development EMA, European Commission, NSCLC, Novartis

The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …
News
shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017 Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …
News
brainss

Enzyme able to untangle protein aggregates associated with Alzheimer’s

June 29, 2017 Research and Development Alzheimer's, Parkinson's

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …
News
tablets-1796506_960_720

Researchers in world-first study on antibiotic use for sepsis

June 28, 2017 Research and Development NHS, antibiotic, sepsis

The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025